recombinant alpha-2a interferon ( ifn alpha-2a ; roferon-a ) was administered as adjuvant therapy in 21 patients with malignant melanoma stage iia or iib after surgical removal of all detectable metastases .
C0021735
recombinant alpha-2a interferon
C0021734
ifn alpha-2a